Home > Insider Trading > Filing (0001209191-13-018476)

Filing Details

Accession Number:: 0001209191-13-018476
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-03-26 17:24:24
Reporting Period:: 2013-03-22

Filing Date:: 2013-03-26
Accepted Time:: 2013-03-26 17:24:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1254419	Medassets Inc	MDAS	Services-Prepackaged Software (7372)	510391128

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1516879	O Charles Garner	100 North Point Center East Suite 200 Alpharetta GA 30022	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-03-22	7,234	$15.95	7,234	No	4	M	Direct
Common Stock	Acquisiton	2013-03-22	7,804	$0.00	15,038	No	4	M	Direct
Common Stock	Disposition	2013-03-22	14,334	$19.37	704	No	4	S	Direct
Common Stock	Disposition	2013-03-25	704	$19.50	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2013-03-22	7,234	$0.00	7,234	$15.95
Common Stock	Stock-Settled Stock Appreciation Rights	Disposition	2013-03-22	15,910	$0.00	15,910	$14.74
Common Stock	Stock-Settled Stock Appreciation Rights	Disposition	2013-03-22	45,998	$0.00	45,998	$16.04

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2018-03-25	No	4	M	Direct
0	2016-01-05	No	4	M	Direct
74,002	2018-05-09	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership
Restricted Stock	108,000	Direct
Restricted Stock	5,233	Direct
Restricted Stock	7,849	Direct
Restricted Stock	7,849	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 31, 2012.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.29 to $19.54, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.
The reporting person was granted these restricted shares on May 9, 2011. The shares vest 20% annually beginning on December 31, 2011 such that all shares will be fully vested on December 31, 2015.
The reporting person was granted these service-based restricted shares on February 25, 2013. The shares vest approximately 33.3% on each of March 1, 2014, 2015 and 2016.
The reporting person was granted these performance-based restricted shares on February 25, 2013. The shares vest approximately 33.3% on each of March 1, 2014, 2015 and 2016 based on the achievement of certain Company financial performance targets for fiscal year 2013.
The reporting person was granted these stock options on March 25, 2008 and are fully vested.
The reporting person was granted these stock-settled stock appreciation rights (SSARs) on January 5, 2009 and are fully vested.
The reporting person was granted these SSARs on May 9, 2011. The SSARs vest equally (over the course of 60 months) beginning on May 1, 2011 such that 100% of the SSARs will be fully vested on April 1, 2016.